Amarin Corp

Latest Amarin Corp News and Updates

  • Amarin Stock Looks Like a Good Buy for Investors
    Healthcare

    Amarin Expects More Growth in 2021, Stock Looks Like a Buy

    On Jan. 22, a Cowen analyst said that Amarin stock remains undervalued under any scenario. Is AMRN stock a good buy for investors in 2021?
    By Ambrish Shah
  • uploads///euro _
    Company & Industry Overviews

    Why Amarin Is Soaring in First Half of January

    Amarin has been rising on rumors about pharmaceutical giant Pfizer (PFE) being interested in acquiring the company.

    By Margaret Patrick
  • vascepa hearing amarin stock
    Healthcare

    Amarin Stock Drops After Vascepa Appeal Hearing

    Amarin stock dropped 31 percent yesterday in response to the company’s Vascepa appeal hearing.
    By Ambrish Shah
  • uploads///michele blackwell przZDqzZKpk unsplash
    Company & Industry Overviews

    How Much Higher Can Amarin Stock Surge?

    In the November 15 premarket trading session, Amarin Corporation (AMRN) stock rose more than 7%, caused by the FDA positive decision for Vascepa.

    By Oleksandr Pylypenko
  • uploads///pill _
    Healthcare

    Why Ligand Pharmaceuticals Tanked 25%

    Today, US pharmaceutical firm Ligand Pharmaceuticals (LGND) fell 25% from yesterday’s closing price to a low of $98.86 for the day.

    By Jitendra Parashar
  • uploads///pills _
    Earnings Report

    What Wall Street Recommends for Amarin after Q4 2018 Results

    On February 27, Amarin (AMRN) closed at $21.18, 5.85% higher than its previous closing price, 801.28% higher than its 52-week low of $2.35, and 9.24% below its 52-week high of $23.33.

    By Margaret Patrick
  • uploads///fish oil _
    Company & Industry Overviews

    What Wall Street Recommends for Amarin and Novavax

    On February 22, Amarin (AMRN) closed at $19.87, 14% higher than its previous closing price and 746% higher than its 52-week low of $2.35.

    By Margaret Patrick
  • © Copyright 2022 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.